(Q35155893)

6 August 2017

title

Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience (English)

1 reference

6 August 2017

4

Claus G Roehrborn

1 reference

6 August 2017

3

David A Pistenmaa

1 reference

6 August 2017

Stanley L Liauw

1

1 reference

6 August 2017

W Scott Webster

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

61

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

1204-1210

1 reference

6 August 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Efficacy and limitations of delayed/salvage radiation therapy after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Percent of cancer in the biopsy set predicts pathological findings after prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

Lymphovascular invasion as a predictor of disease progression in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900044-X

7 January 2021

10.1016/S0090-4295(03)00044-X

Identifiers

DOI

1 reference

6 August 2017

1 reference